Bahrain has approved the Pfizer COVID-19 vaccine for emergency use for children aged between 5 and 11 years, the government media office said on Tuesday.
The decision came after a study involving 3,100 children aged between 5 and 11 were administered with the vaccine found it to be 90.7 per cent effecting in that age group, said the statement, citing the National Health Regulatory Authority.
None of the children involved in the study showed severe side effects, it added.
Bahrain will be supplied with doses from the manufacturer for the 5-11 age group from the start of 2022, it said.
Thai teen kills 7 in rampage at home and school before shooting himself
Syria says bomb on minibus near Damascus wounded 14, deaths reported mistakenly
Morocco to cooperate on return of minors from Spain after Ceuta crossing
North Korea fires short-range ballistic missile, South Korea says
Wildfire prompts evacuation alert in metro Vancouver
